No Data
No Data
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down
Haemonetics Announces EVP Josep Llorens' Retirement
Here's Why You Should Add HAE Stock to Your Portfolio Now
Earnings Grew Faster Than the Favorable 12% CAGR Delivered to Haemonetics (NYSE:HAE) Shareholders Over the Last Three Years
Down -11.82% in 4 Weeks, Here's Why You Should You Buy the Dip in Haemonetics (HAE)
No Data